Sprint Bioscience AB (publ) (FRA:5JA1)

Sprint Bioscience AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	22	14	10	11	2	19
Market Cap Growth	122.75%	48.68%	-11.54%	450.99%	-89.35%	14.56%
Enterprise Value	10	13	7	6	-0	10
Last Close Price	0.18	0.12	0.13	0.12	0.03	0.44
PE Ratio	2.58	1.69	-	-	-	-
PS Ratio	1.41	0.93	1.67	2.34	265.47	5.45
PB Ratio	1.98	1.30	11.91	4.36	0.78	2.71
P/TBV Ratio	1.98	1.30	11.91	4.36	0.78	2.71
P/FCF Ratio	2.83	1.86	-	5.93	-	-
P/OCF Ratio	2.83	1.86	-	5.30	-	-
EV/Sales Ratio	0.64	0.86	1.19	1.28	-	3.01
EV/EBITDA Ratio	1.08	1.47	-	-	-	-
EV/EBIT Ratio	1.09	1.48	-	-	-	-
EV/FCF Ratio	1.29	1.73	-	3.24	-	-
Net Debt / Equity Ratio	-1.06	-1.06	-2.70	-1.80	-1.05	-1.00
Net Debt / EBITDA Ratio	-1.29	-1.29	1.41	57.00	0.49	2.84
Net Debt / FCF Ratio	-1.52	-1.52	1.02	-2.45	0.50	1.65
Asset Turnover	1.88	1.88	1.27	1.04	0.00	0.62
Quick Ratio	7.60	7.60	1.14	1.67	3.78	8.74
Current Ratio	7.60	7.60	1.14	1.67	3.78	8.74
Return on Equity (ROE)	142.84%	142.84%	-98.67%	-1.57%	-122.00%	-63.02%
Return on Assets (ROA)	68.05%	68.05%	-22.46%	-1.66%	-65.01%	-28.29%
Return on Capital Employed (ROCE)	81.60%	81.60%	-202.40%	-4.80%	-215.00%	-36.10%
Earnings Yield	38.82%	59.14%	-16.55%	-0.36%	-273.08%	-13.13%
FCF Yield	35.31%	53.79%	-22.32%	16.85%	-268.02%	-22.41%
Buyback Yield / Dilution	-32.63%	-32.63%	-0.01%	-65.98%	-45.85%	-71.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.